Matthew J. Baggott

2.1k total citations
36 papers, 1.4k citations indexed

About

Matthew J. Baggott is a scholar working on Clinical Psychology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Matthew J. Baggott has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Clinical Psychology, 15 papers in Cellular and Molecular Neuroscience and 13 papers in Pharmacology. Recurrent topics in Matthew J. Baggott's work include Psychedelics and Drug Studies (21 papers), Neurotransmitter Receptor Influence on Behavior (15 papers) and Forensic Toxicology and Drug Analysis (11 papers). Matthew J. Baggott is often cited by papers focused on Psychedelics and Drug Studies (21 papers), Neurotransmitter Receptor Influence on Behavior (15 papers) and Forensic Toxicology and Drug Analysis (11 papers). Matthew J. Baggott collaborates with scholars based in United States, United Kingdom and New Zealand. Matthew J. Baggott's co-authors include John Mendelson, Harriet de Wit, Jessica Weafer, Reese T. Jones, Gantt P. Galloway, Susette Welm, Jeremy Coyle, Debra Harris, Jack H. Mendelson and Fire Erowid and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Journal of Neurophysiology.

In The Last Decade

Matthew J. Baggott

34 papers receiving 1.3k citations

Peers

Countries citing papers authored by Matthew J. Baggott

Since Specialization

Citations

This map shows the geographic impact of Matthew J. Baggott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Baggott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Baggott more than expected).

Fields of papers citing papers by Matthew J. Baggott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Baggott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Baggott. The network helps show where Matthew J. Baggott may publish in the future.

Co-authorship network of co-authors of Matthew J. Baggott

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Baggott. A scholar is included among the top collaborators of Matthew J. Baggott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Baggott. Matthew J. Baggott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel Benzofuran Derivatives Induce Monoamine Release and Substitute for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine 2024 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Donna Walther, Matthew J. Baggott, Lisa E. Baker, Michael H. Baumann	0
2	Learning about STP 2023 ·Matthew J. Baggott	1
3	Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting 2016 ·Journal of Psychopharmacology ·Matthew J. Baggott, Jeremy Coyle, (unknown), (unknown), Gantt P. Galloway, John Mendelson	47
4	MDMA Impairs Response to Water Intake in Healthy Volunteers 2016 ·Advances in Pharmacological Sciences ·Matthew J. Baggott, (unknown), Jeremy Coyle, Gantt P. Galloway, Allan J. Barnes, Marilyn A. Huestis, John Mendelson	10
5	Psychedelics and creativity: a review of the quantitative literature 2015 ·Matthew J. Baggott	5
6	Psychedelics and creativity: a review of the quantitative literature 2015 ·Matthew J. Baggott	25
7	MDMA effects consistent across laboratories 2014 ·Psychopharmacology ·Matthew G. Kirkpatrick, Matthew J. Baggott, John Mendelson, Gantt P. Galloway, Matthias E. Liechti, Cédric M. Hysek, Harriet de Wit	48
8	Test–retest reliability of behavioral measures of impulsive choice, impulsive action, and inattention. 2013 ·Experimental and Clinical Psychopharmacology ·Jessica Weafer, Matthew J. Baggott, Harriet de Wit	175
9	Ketamine is associated with lower urinary tract signs and symptoms 2013 ·Drug and Alcohol Dependence ·Ruma Pal, (unknown), Earth Erowid, Fire Erowid, Matthew J. Baggott, John Mendelson, (unknown)	24
10	Mechanisms and Genetics of Antipsychotic-Associated Weight Gain 2011 ·Clinical Pharmacology & Therapeutics ·(unknown), (unknown), Matthew J. Baggott, (unknown), John Mendelson	38
11	Developing Biomarkers for Methamphetamine Addiction 2011 ·Current Neuropharmacology ·John Mendelson, Matthew J. Baggott, Keith Flower, Gantt P. Galloway	10
12	Use patterns and self-reported effects of Salvia divinorum: An internet-based survey 2010 ·Drug and Alcohol Dependence ·Matthew J. Baggott, Earth Erowid, Fire Erowid, Gantt P. Galloway, John Mendelson	65
13	A Randomized, Placebo-Controlled Trial of Sustained-Release Dextroamphetamine for Treatment of Methamphetamine Addiction 2010 ·Clinical Pharmacology & Therapeutics ·(unknown), (unknown), Jeremy Coyle, Keith Flower, (unknown), (unknown), Matthew J. Baggott, (unknown), Douglas L. Polcin, (unknown), John Mendelson	68
14	Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire 2010 ·Drug and Alcohol Dependence ·Matthew J. Baggott, Jeremy Coyle, Earth Erowid, Fire Erowid, Lynn C. Robertson	53
15	Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans 2010 ·PLoS ONE ·Matthew J. Baggott, (unknown), Gantt P. Galloway, Lynn C. Robertson, Jeremy Coyle, John Mendelson	15
16	Estimating the Intake of Abused Methamphetamines Using Experimenter-Administered Deuterium Labeled R-Methamphetamine: Selection of the R-Methamphetamine Dose 2010 ·Therapeutic Drug Monitoring ·Linghui Li, (unknown), Gantt P. Galloway, Matthew J. Baggott, (unknown), John Mendelson	11
17	The effects of inhaled L-methamphetamine on athletic performance while riding a stationary bike: a randomised placebo-controlled trial 2008 ·British Journal of Sports Medicine ·(unknown), (unknown), Matthew J. Baggott, John Mendelson	10
18	Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans 2002 ·Psychopharmacology ·Debra Harris, Matthew J. Baggott, Jack H. Mendelson, John Mendelson, Reese T. Jones	169
19	Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers 1999 ·Psychopharmacology ·John Mendelson, Reese T. Jones, Susette Welm, Matthew J. Baggott, (unknown), (unknown), Rajneesh Nath	83
20	Buprenorphine and naloxone interactions in opiate-dependent volunteers* 1996 ·Clinical Pharmacology & Therapeutics ·John Mendelson, Reese T. Jones, (unknown), Susette Welm, (unknown), Matthew J. Baggott	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact